Comen, Aljane T.
HRN: 15-83-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFUROXIME 500MG (TAB)
11/24/2025
12/01/2025
ORAL
500mg
BID
S/P Repeat CS With BTL
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines